Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EGZQD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SBT-8230
|
|||||
| Synonyms |
SBT8230; SBT 8230; Asgr1-Tlr8; Asgr1-Tlr8-S; ASGR1-TLR8 ImmunoTAC conjugate
Click to Show/Hide
|
|||||
| Organization |
Silverback Therapeutics, Inc.; ARS Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Hepatitis B viral hepatitis [ICD11:1E50]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Asialoglycoprotein receptor 1 (ASGR1)
|
Antigen Info | ||||
| Payload Name |
TLR8 agonist
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.